NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states.

N-myc downstream-regulated gene 1 (NDRG1) is an intracellular protein that is induced under a wide variety of stress and cell growth-regulatory conditions. NDRG1 is up-regulated by cell differentiation signals in various cancer cell lines and suppresses tumor metastasis. Despite its specific role in the molecular cause of Charcot-Marie-Tooth type 4D disease, there has been more interest in the gene as a marker of tumor progression and enhancer of cellular differentiation. Because it is strongly up-regulated under hypoxic conditions, and this condition is prevalent in solid tumors, its regulation is somewhat complex, governed by hypoxia-inducible factor 1 alpha (HIF-1alpha)- and p53-dependent pathways, as well as its namesake, neuroblastoma-derived myelocytomatosis, and probably many other factors, at the transcriptional and translational levels, and through mRNA stability. We survey the data for clues to the NDRG1 gene's mechanism and for indications that the NDRG1 gene may be an efficient diagnostic tool and therapy in many types of cancers.

[1]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[2]  A. Koong,et al.  Hypoxia Causes the Activation of Nuclear Factor κB through the Phosphorylation of IκBα on Tyrosine Residues , 1994 .

[3]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.

[4]  J. Milbrandt,et al.  Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Hristova,et al.  Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24 , 1996, Nature Genetics.

[6]  J. Milbrandt,et al.  NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli , 1996, Molecular and cellular biology.

[7]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[8]  M. Goldberg,et al.  Hypoxia-inducible Protein Binding to Vascular Endothelial Growth Factor mRNA and Its Modulation by the von Hippel-Lindau Protein* , 1996, The Journal of Biological Chemistry.

[9]  T. Miyata,et al.  Homocysteine-respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis , 1996, The Journal of Biological Chemistry.

[10]  S. Bhattacharya,et al.  An essential role for p300/CBP in the cellular response to hypoxia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Wande Li,et al.  Nickel (Ni2+) Enhancement of α-Tubulin Acetylation in Cultured 3T3 Cells , 1996 .

[12]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[13]  T. Commes,et al.  Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways , 1997, Leukemia.

[14]  E. Mekada,et al.  c-myc activates RCC1 gene expression through E-box elements , 1997, Oncogene.

[15]  D. Mukhopadhyay,et al.  The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity , 1997, Molecular and cellular biology.

[16]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[17]  J. Lupski,et al.  Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies , 1998, Nature Genetics.

[18]  L. Poellinger,et al.  Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of theCBP/p300 coactivator by the hypoxia‐induciblefactor‐1α , 1998, The EMBO journal.

[19]  A. Hristova,et al.  Hereditary motor and sensory neuropathy--Lom, a novel demyelinating neuropathy associated with deafness in gypsies. Clinical, electrophysiological and nerve biopsy findings. , 1998, Brain : a journal of neurology.

[20]  ChengXiang Zhai,et al.  Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Neckers,et al.  Stabilization of wild-type p53 by hypoxia-inducible factor 1α , 1998, Nature.

[22]  Y. Bobryshev,et al.  The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions. , 1998, Cardiovascular research.

[23]  T. Miyata,et al.  Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others. , 1998, Journal of biochemistry.

[24]  K. Salnikow,et al.  Cap43, a novel gene specifically induced by Ni2+ compounds. , 1998, Cancer research.

[25]  K. Webster,et al.  Hypoxia Regulates β-Enolase and Pyruvate Kinase-M Promoters by Modulating Sp1/Sp3 Binding to a Conserved GC Element* , 1998, The Journal of Biological Chemistry.

[26]  Y. Zou,et al.  Hypoxia-associated Induction of Early Growth Response-1 Gene Expression* , 1999, The Journal of Biological Chemistry.

[27]  H. Kondoh,et al.  N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant , 1999, Mechanisms of Development.

[28]  K. Salnikow,et al.  Role of Ca(2+) in the regulation of nickel-inducible Cap43 gene expression. , 1999, Toxicology and applied pharmacology.

[29]  K. Kinzler,et al.  Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Blagosklonny,et al.  Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. , 1999, Carcinogenesis.

[31]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[32]  T. Commes,et al.  Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. , 1999, Biochimica et biophysica acta.

[33]  R. Wisdom,et al.  AP-1: one switch for many signals. , 1999, Experimental cell research.

[34]  M. Blagosklonny,et al.  Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism. , 2000, Cancer research.

[35]  H. Ford,et al.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.

[36]  Nigel Mackman,et al.  Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.

[37]  F. Baas,et al.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. , 2000, American journal of human genetics.

[38]  M. Blagosklonny,et al.  Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. , 2000, Cancer research.

[39]  David S. McClintock,et al.  Role of Oxidants in NF-κB Activation and TNF-α Gene Transcription Induced by Hypoxia and Endotoxin1 , 2000, The Journal of Immunology.

[40]  Q. Xu,et al.  Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium , 2000, The Journal of Biological Chemistry.

[41]  M. Blagosklonny,et al.  Carcinogenic nickel induces genes involved with hypoxic stress. , 2000, Cancer research.

[42]  T. Miyata,et al.  Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. , 2001, Genomics.

[43]  G. Semenza,et al.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .

[44]  H. Kondoh,et al.  The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells , 2001, Leukemia.

[45]  U. Suter,et al.  Molecular cell biology of Charcot-Marie-Tooth disease , 2002, Neurogenetics.

[46]  P. Ratcliffe,et al.  Oxygen sensors and angiogenesis. , 2002, Seminars in cell & developmental biology.

[47]  Giuseppe Cibelli,et al.  Regulation of life and death by the zinc finger transcription factor Egr‐1 , 2002, Journal of cellular physiology.

[48]  M. Blagosklonny,et al.  The Regulation of Hypoxic Genes by Calcium Involves c-Jun/AP-1, Which Cooperates with Hypoxia-Inducible Factor 1 in Response to Hypoxia , 2002, Molecular and Cellular Biology.

[49]  S. Samson,et al.  Role of Sp1 in insulin regulation of gene expression. , 2002, Journal of molecular endocrinology.

[50]  F. Bosman,et al.  Expression of NDRG1, a differentiation-related gene, in human tissues , 2002, Histochemistry and Cell Biology.

[51]  L. Penn,et al.  The myc oncogene: MarvelouslY Complex. , 2002, Advances in cancer research.

[52]  T. Moon,et al.  Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. , 2003, Biochemical and biophysical research communications.

[53]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[54]  K. Shazand,et al.  Large scale validation of human N-myc downstream-regulated gene (NDRG)-1 expression in endometrium during the menstrual cycle. , 2003, Molecular human reproduction.

[55]  T. Shuin,et al.  Downregulation of Cap43 gene by von Hippel‐Lindau tumor suppressor protein in human renal cancer cells , 2003, International journal of cancer.

[56]  Ying Wang,et al.  PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer , 2004, Cancer Research.

[57]  M. Westfall,et al.  NDRG1 Is Necessary for p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[58]  T. Miyata,et al.  Ndrg1-Deficient Mice Exhibit a Progressive Demyelinating Disorder of Peripheral Nerves , 2004, Molecular and Cellular Biology.

[59]  H. Yee,et al.  Enhanced Expression of a Novel Protein in Human Cancer Cells: A Potential Aid to Cancer Diagnosis , 2004, Cell Biology and Toxicology.

[60]  A. Zhitkovich,et al.  Depletion of Intracellular Ascorbate by the Carcinogenic Metals Nickel and Cobalt Results in the Induction of Hypoxic Stress* , 2004, Journal of Biological Chemistry.

[61]  P. Ongusaha,et al.  Function of Drg1/Rit42 in p53-dependent Mitotic Spindle Checkpoint* , 2004, Journal of Biological Chemistry.

[62]  D. Richardson,et al.  Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. , 2004, Blood.

[63]  Fuchu He,et al.  Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family , 2004, Molecular and Cellular Biochemistry.

[64]  Minhyung Lee,et al.  Sp1‐dependent regulation of the tissue inhibitor of metalloproteinases‐1 promoter , 2004, Journal of cellular biochemistry.

[65]  M. Ikuta,et al.  Hypoxia-induced Activation of the Retinoic Acid Receptor-related Orphan Receptor α4 Gene by an Interaction between Hypoxia-inducible Factor-1 and Sp1* , 2004, Journal of Biological Chemistry.

[66]  S. Colgan,et al.  HIF-1–dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia , 2005, The Journal of experimental medicine.

[67]  Antonio Porro,et al.  In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. Schmidt,et al.  Nab proteins are essential for peripheral nervous system myelination , 2005, Nature Neuroscience.

[69]  S. Lowe,et al.  A conserved element in Myc that negatively regulates its proapoptotic activity , 2005, EMBO reports.

[70]  J. Pouysségur,et al.  The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. , 2006, Bulletin du cancer.

[71]  M. Cole,et al.  A Conserved Myc Protein Domain, MBIV, Regulates DNA Binding, Apoptosis, Transformation, and G2 Arrest , 2006, Molecular and Cellular Biology.

[72]  Hua Han,et al.  The Repression of Human Differentiation-related Gene NDRG2 Expression by Myc via Miz-1-dependent Interaction with the NDRG2 Core Promoter* , 2006, Journal of Biological Chemistry.

[73]  M. Henriksson,et al.  The Myc oncoprotein as a therapeutic target for human cancer. , 2006, Seminars in cancer biology.

[74]  R. Shaw,et al.  Glucose metabolism and cancer. , 2006, Current opinion in cell biology.

[75]  F. Marshall,et al.  cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis , 2007, Oncogene.

[76]  D. Ross,et al.  Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma , 2007, Modern Pathology.